# Activation of the Cannabinoid Receptor Type 2 Reduces Brain and Spinal Cord Damage During Ischemia-Reperfusion Injury > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/activation-cannabinoid-receptor-type-2-brain-spinal-cord-protection/ > **Published:** 2021-01-26T14:18:04-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:17:16-04:00 > **Clinical Summary:** Activation cannabinoid receptor type 2 reduces brain damage and spinal cord disruptions during ischemia-reperfusion injury by modulating key molecular pathways. --- ### Exogenous activation of cannabinoid-2 receptor modulates TLR4/MMP9 expression in a spinal cord ischemia reperfusion rat model ​In Summary Ischemia is the restriction in blood supply, causing a shortage of oxygen and resulting in damage to the tissue. However, if blood supply suddenly returns to the affected tissue after a period of ischemia, it can undergo inflammation and stress that lead to further damage. This phenomenon often follows stroke, and is known as ischemia-reperfusion injury (IRJ), a serious condition that occurs to many organs including the brain and spinal cord and can even cause multisystem organ failure. For this reason, an understanding of the molecular events in our organs during IRJ is crucial because it can help alleviate the devastating consequences of this injury. ​ Researchers have recently identified the important role of the cannabinoid receptor type 2 (CB2R) in the cascading molecular events during IRJ. In particular, when CB2R is activated, it inhibits a signalling pathway that would normally lead to [blood-brain barrier](https://cedclinic.com/thc-blood-brain-barrier-endocannabinoid-system-patience/) dysfunction. Therefore, activation of CB2R decreases the damage to the brain and the disruption to the spinal cord during IRJ. Because cannabinoids, compounds that can be found in the plant cannabis, can interact with and activate CB2R, this finding has unearthed a promising application of cannabinoids in treating IRJ. [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [An unknown cannabinoid receptor helps alleviate secondary brain damages through regulating microglial cells and astrocytes of the brain.](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/) Explore how a newly discovered cannabinoid receptor aids in reducing brain damage by modulating brain immune cells. [Read More](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/) [Citral, a natural activator of the cannabinoid receptor type 2, can help combat pain and inflammatory conditions](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/) Learn about citral’s role as a natural activator of [CB2 receptor](https://cedclinic.com/s-caryophyllene-a-terpine-found-in-cannabis-demonstrates-therapeutic-potential-in-a-mouse-model-of-ms/) and its potential benefits for pain and inflammation. [Discover More](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/) [Activation of cannabinoid receptor-2 in spinal cord improves the integrity of the blood–spinal cord barrier and reduces bone cancer pain](https://cedclinic.com/blood-spinal-cord-barrier-integrity-cb2-activation-bone-cancer-pain/) This article discusses how [CB2 receptor](https://cedclinic.com/s-caryophyllene-a-terpine-found-in-cannabis-demonstrates-therapeutic-potential-in-a-mouse-model-of-ms/) activation enhances spinal cord barrier integrity and alleviates pain. [Learn More](https://cedclinic.com/blood-spinal-cord-barrier-integrity-cb2-activation-bone-cancer-pain/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Activation%20of%20the%20Cannabinoid%20Receptor%20Type%202%20Reduces%20Brain%20and%20Spinal%20Cord%20Damage%20During%20Ischemia-Reperfusion%20Injury&url=https%3A%2F%2Fcedclinic.com%2Factivation-cannabinoid-receptor-type-2-brain-spinal-cord-protection%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Factivation-cannabinoid-receptor-type-2-brain-spinal-cord-protection%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Activation%20of%20the%20Cannabinoid%20Receptor%20Type%202%20Reduces%20Brain%20and%20Spinal%20Cord%20Damage%20During%20Ischemia-Reperfusion%20Injury%20https%3A%2F%2Fcedclinic.com%2Factivation-cannabinoid-receptor-type-2-brain-spinal-cord-protection%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).